MedTrace Logo

Telephone Versus Videoconference Communication for Remote Genetic Disclosure in the APOE4 Trial

NCT02978729 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 613

Last updated 2020-11-19

No results posted yet for this study

Summary

The purpose of this study is to compare two methods for remote genetic counseling (telephone and two-way videoconferencing) for patients who are receiving disclosure of their APOE (apolipoprotein E) genotype. The target population will consist of males and females in the age range of 60-75 years who, as potential participants in a study (Generation Study), will need to receive genetic counseling and disclosure of APOE genotype. Subjects must be willing to receive genetic counseling and disclosure remotely. Subjects must be willing to be randomized to either telephone arm or videoconference arm.

Conditions

  • Alzheimer Disease
  • Genetic Predisposition to Disease

Interventions

OTHER

Two-way videoconference remote genetic counseling

OTHER

Telephone remote genetic counseling

Sponsors & Collaborators

Principal Investigators

  • Angela R Bradbury, MD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2019-07-11
Completion
2019-07-11

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02978729 on ClinicalTrials.gov